Evidence map›Paper›PMID 32552804›Full record

ArticleSubstance abuse treatment, prevention, and policy2020

Substance use disorders in Saudi Arabia: a scoping review.

Nazmus Saquib, Ahmad Mamoun Rajab, Juliann Saquib, AbdulRahman AlMazrou

Open access · goldAbstract readScoping Review
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nazmus SaquibCollege of Medicine, Sulaiman Al Rajhi University, PO Box 777, Bukairyah, Al-Qassim, 51941, Saudi Arabia. a.saquib@sr.edu.sa.ORCID 0000-0002-2819-2839
Ahmad Mamoun RajabCollege of Medicine, Sulaiman Al Rajhi University, PO Box 777, Bukairyah, Al-Qassim, 51941, Saudi Arabia.ORCID 0000-0001-5862-7445
Juliann SaquibCollege of Medicine, Sulaiman Al Rajhi University, PO Box 777, Bukairyah, Al-Qassim, 51941, Saudi Arabia.ORCID 0000-0003-2572-0592
AbdulRahman AlMazrouCollege of Medicine, Sulaiman Al Rajhi University, PO Box 777, Bukairyah, Al-Qassim, 51941, Saudi Arabia.ORCID 0000-0003-2543-6807
Sulaiman Al Rajhi Colleges · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance use disorders (SUD) are mental health conditions that arise from chronic drug use. There is an increased recognition of this problem in Saudi Arabia.

objectiveConduct a comprehensive review of published literature on SUD to identify knowledge gaps and to guide future research.

methodsPubMed, Embase and Cochrane databases were searched with suitable keywords for SUD publications up to June 10, 2019. Eligible studies (primary research conducted in Saudi Arabia) were organized into three broad domains: (1) risk (or protective) factors of SUD, (2) perspectives on drug use of people who use drugs, and (3) impact on family. The quality of the included studies was assessed with the Newcastle-Ottawa Scale.

resultsOf the 113 search records, 23 were eligible for analysis (19 cross-sectional and 4 case-control). All studies were conducted in clinical settings; all but two included males only. There were 4 studies about SUD risk factors, 6 studies about the perspectives of people who use drugs, and none about family impact. None of the cross-sectional studies (0%) and 25% of case-control studies were of good quality.

conclusionsThe available studies were few in number, weak in methodology, and poor in quality. Quantitative as well as qualitative studies about SUD are warranted in each domain and should represent both genders.

Indexed as

Case-Control StudiesComorbidityCross-Sectional StudiesFamily RelationsHumansRecurrenceRisk FactorsSaudi ArabiaSeverity of Illness IndexSubstance-Related DisordersQualityReviewSaudi ArabiaSubstance use disorder

Identifiers

PMID32552804
PMCPMC7301978
OpenAlexW3036993245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.